When it comes to group Mix vs. Pro-Meta, CDKN2A (Cyclin Dependent Kinase Inhibitor 2 A) seems specifically mutated in the Mix group and is known to be an important tumor suppressor gene, indicating a disordered cell cycle in this group (Fig. 4C). Here, CDKN2A is linked to neoplasm.